Publication:
Part 1: Defining unproven cellular therapies.

Simple item page
dc.contributor.authorSrivastava, Alok
dc.contributor.authorMason, Chris
dc.contributor.authorWagena, Edwin
dc.contributor.authorCuende, Natividad
dc.contributor.authorWeiss, Daniel J
dc.contributor.authorHorwitz, Edwin M
dc.contributor.authorDominici, Massimo
dc.date.accessioned2023-01-25T08:30:29Z
dc.date.available2023-01-25T08:30:29Z
dc.date.issued2016
dc.identifier.doi10.1016/j.jcyt.2015.11.004
dc.identifier.essn1477-2566
dc.identifier.pmid26719202
dc.identifier.unpaywallURLhttps://iris.unimore.it/bitstream/11380/1117726/1/Part.1%20.pdf
dc.identifier.urihttp://hdl.handle.net/10668/9692
dc.issue.number1
dc.journal.titleCytotherapy
dc.journal.titleabbreviationCytotherapy
dc.language.isoen
dc.organizationFundación Pública Andaluz Progreso y Salud-FPS
dc.page.number117-9
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titlePart 1: Defining unproven cellular therapies.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number18
dspace.entity.typePublication

Files

Collections

Fundación Pública Andaluza Progreso y Salud

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía